Santen Pharmaceutical Co Stock Market Value
| SNPHY Stock | USD 9.51 0.10 1.06% |
| Symbol | Santen |
Santen Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Santen Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Santen Pharmaceutical.
| 05/04/2022 |
| 04/23/2024 |
If you would invest 0.00 in Santen Pharmaceutical on May 4, 2022 and sell it all today you would earn a total of 0.00 from holding Santen Pharmaceutical Co or generate 0.0% return on investment in Santen Pharmaceutical over 720 days. Santen Pharmaceutical is related to or competes with Eli Lilly, Johnson Johnson, Merck, Roche Holding, AstraZeneca PLC, and Novartis. Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices i... More
Santen Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Santen Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Santen Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 16.78 | |||
| Value At Risk | (3.90) | |||
| Potential Upside | 4.05 |
Santen Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Santen Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Santen Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Santen Pharmaceutical historical prices to predict the future Santen Pharmaceutical's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.14) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Santen Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Santen Pharmaceutical Backtested Returns
Santen Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0261, which indicates the firm had a -0.0261% return per unit of risk over the last 3 months. Santen Pharmaceutical Co exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Santen Pharmaceutical's Risk Adjusted Performance of (0), variance of 6.48, and Coefficient Of Variation of (6,003) to confirm the risk estimate we provide. The entity has a beta of 0.38, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Santen Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Santen Pharmaceutical is expected to be smaller as well. Santen Pharmaceutical has an expected return of -0.0681%. Please make sure to validate Santen Pharmaceutical treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Santen Pharmaceutical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.09 |
Virtually no predictability
Santen Pharmaceutical Co has virtually no predictability. Overlapping area represents the amount of predictability between Santen Pharmaceutical time series from 4th of May 2022 to 29th of April 2023 and 29th of April 2023 to 23rd of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Santen Pharmaceutical price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Santen Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.3 |
Santen Pharmaceutical lagged returns against current returns
Autocorrelation, which is Santen Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Santen Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of Santen Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Santen Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Santen Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Santen Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Santen Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Santen Pharmaceutical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Santen Pharmaceutical Lagged Returns
When evaluating Santen Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Santen Pharmaceutical pink sheet have on its future price. Santen Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Santen Pharmaceutical autocorrelation shows the relationship between Santen Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Santen Pharmaceutical Co.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Check out Santen Pharmaceutical Correlation, Santen Pharmaceutical Volatility and Santen Pharmaceutical Alpha and Beta module to complement your research on Santen Pharmaceutical. Note that the Santen Pharmaceutical information on this page should be used as a complementary analysis to other Santen Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Santen Pink Sheet analysis
When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Santen Pharmaceutical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.